Randomized Controlled Trial
doi: 10.1007/s00120-015-4031-9.
[Clarification regarding criticism on PREFERE]
[Article in
German]
Affiliations
- PMID: 26704281
- DOI: 10.1007/s00120-015-4031-9
Item in Clipboard
Randomized Controlled Trial
[Clarification regarding criticism on PREFERE]
[Article in
German]
Urologe A.
2015 Dec.
No abstract available
Similar articles
-
[Comparison of four treatment options for low-risk prostate cancer: Preference-based randomized study for the evaluation of four treatment modalities in prostate cancer with low or "early intermediate" risk (PREFERE) - trial AP 65/11 of the AUO].Urologe A. 2015 May;54(5):723-5. doi: 10.1007/s00120-015-3816-1. Urologe A. 2015. PMID: 25802104 Clinical Trial. German. No abstract available.
-
[PREFERE--the German prostatic cancer study].Urologe A. 2014 Mar;53(3):388-9. doi: 10.1007/s00120-013-3286-2. Urologe A. 2014. PMID: 23975217 German. No abstract available.
-
[PREFERE--the German prostatic cancer study].Urologe A. 2014 Mar;53(3):387. doi: 10.1007/s00120-013-3285-3. Urologe A. 2014. PMID: 23975216 German. No abstract available.
-
[Second neoplasms after percutaneous radiotherapy].Urologe A. 2017 Mar;56(3):342-350. doi: 10.1007/s00120-016-0277-0. Urologe A. 2017. PMID: 27844130 Review. German.
-
Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.Prescrire Int. 2012 Oct;21(131):242-8. Prescrire Int. 2012. PMID: 23185849 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
